Next Article in Journal
High Level of Knowledge about Tungiasis but Little Translation into Control Practices in Karamoja, Northeastern Uganda
Previous Article in Journal
Comparing Catastrophic Costs: Active vs. Passive Tuberculosis Case Finding in Urban Vietnam
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Factors Associated with COVID-19 Vaccine Refusal: A Community-Based Study in the Menoua Division in Cameroon

by
Aimé Césaire Momo Tetsatsi
1,2,3,*,
Astride Arolle Nguena
1,
Andrillene Laure Deutou
1,4,
Alaric Tamuedjoun Talom
1,
Beatrice Talom Metchum
1,
Armand Tsapi Tiotsia
1,
Pierre Watcho
2 and
Vittorio Colizzi
1,4
1
Faculty of Science and Technology, Evangelical University of Cameroon, Bandjoun P.O. Box 127, Cameroon
2
Research Unit of Animal Physiology and Phytopharmacology, University of Dschang, Dschang P.O. Box 67, Cameroon
3
Faculty of Health Sciences, The University of Bamenda, Bambili P.O. Box 39, Cameroon
4
Department of Biology and Interdepartmental Centre for Comparative Medicine, University of Rome Tor Vergata, 00133 Rome, Italy
*
Author to whom correspondence should be addressed.
Trop. Med. Infect. Dis. 2023, 8(9), 424; https://doi.org/10.3390/tropicalmed8090424
Submission received: 17 July 2023 / Revised: 9 August 2023 / Accepted: 14 August 2023 / Published: 24 August 2023
(This article belongs to the Section Infectious Diseases)

Abstract

:
COVID-19, which was named in March 2020 as a global pandemic by the WHO, remains a serious public health threat worldwide. Despite the adoption of vaccines as an effective strategy to counter this pandemic, the vaccination rate in Cameroon is far lower than that planned by the Cameroonian government and its partners. The main objective of this study was to determine the factors limiting COVID-19 vaccine acceptance in the Menoua Division in the West Region of Cameroon. A community-based cross-sectional and analytical study was conducted between March and April 2022 in the Menoua Division. A pre-tested questionnaire was filled out by willing participants of more than 18 years old, and data were further expressed in order to estimate the knowledge of participants on COVID-19, vaccine status, and the factors associated with vaccine refusal. A Pearson test was performed in order to identify the associated factors, with a p-value < 0.05 considered as significant. A total of 520 participants with a mean age of 33.27 ± 12.78 were included. Most had a secondary education level (56.15%), and trade and informal sectors (34.04%) were the main occupations. Knowledge on COVID-19 was average, and it was significantly associated (p < 0.05) with gender and education level. The vaccination rate was 10%, which was six times less than the national target. A lack of information, confidence, and medicinal plant use were all factors significantly associated with vaccine refusal. This pioneer community-based study in Cameroon identified a lack of knowledge, confidence, and medicinal plant use as the leading factors limiting COVID-19 vaccine acceptance in Cameroon. Health authorities should therefore strengthen sensitization in order to tackle the lack of information and the misinformation among the target groups.

1. Introduction

The world was hit in December 2019 by a severe acute respiratory syndrome (SARS), which began in Wuhan, China. The disease was rapidly named, and was further qualified as a global pandemic by the World Health Organization (WHO) in March 2020 [1]. Recent data suggest that over 6.5 million people, including around 1935 in Cameroon, have died from COVID-19 since 2019 [1]. The first case of COVID-19 was registered in Cameroon on the 6 March 2020, and the government adopted a nationwide strategic plan to address the situation [2,3]. The specific COVID-19 transmission mode led to the establishment of barrier measures, including lockdowns, social distancing, widespread stay-at-home orders, isolating suspected cases, quarantining confirmed cases, face masks, and health education on handwashing and environmental hygiene measures in order to control its propagation [4]. Although the strategy proved to be effective in limiting the spread in China and Europe, the effect was very low in Cameroon due to non-observance of these restrictive measures [5]. Based on these reasons, anti-COVID-19 vaccination could be viewed as the best option for African populations to prevent the effects of the virus.
Drug development obeys well-established rules, and it requires a long period to follow adequate steps. COVID-19 vaccination broke the record as the most promptly and massively deployed public health intervention in the history of healthcare [6]. The WHO planned to achieve a vaccination rate of 70% by June 2022. For African countries, a two-step strategy was adopted by at least 10% of the population by September 2021 and 70% by June 2022 [6]. The vaccination campaign was launched in Cameroon on 12 April 2021 with the objective of achieving a 60% vaccination rate in the population by December 2022 [7]. A total of 840 vaccination centers were set up across the country, and four types of vaccines, including BBIBP-CorV (Sinopharm), ChAdOx1, nCoV-19 adenoviral (AZD1222; Oxford- Astra Zeneca), JNJ-78436735 (Ad26.COV2. S; Johnson and Johnson), and BNT162b2 mRNA (Pfizer Biontech), were mobilized through facilitation platforms, such as the COVID-19 Vaccines Global Access initiative [7,8]. On 13 February 2022, the Expanded Program of Immunization of the Cameroon Ministry of Public Health reported that only 2.9% of the general population, of which 5.87% were of the target population, were vaccinated [7]. This figure is consistent with several reports which indicated that during the early stage of vaccination, contrary to 66.53% and 74.47% of COVID-19 vaccine acceptance rates in Burkina Faso and Nigeria, respectively, only 15% of Cameroonians were likely to take the vaccine [4,9]. With a 6% vaccination rate in September 2022, the West Region was far lower than the targeted rate [7,10]. This situation stresses the need to identify and monitor the factors limiting COVID-19 vaccination.
Vaccine hesitancy is defined as the reluctance or refusal to take the vaccine despite accessibility [11]. Even if some studies have reported misinformation, mistrust of vaccine safety and effectiveness, and religion as just some of the factors associated with COVID-19 hesitancy, vaccine hesitancy is a context-dependent phenomenon that should be examined and monitored regarding local reality [4,12,13]. Previous studies have reported that in Cameroon, the lack of confidence in approved vaccines as well as concerns about vaccine side effects were associated with vaccine hesitancy amongst health personnel [6,14]. Still, no community-based study, to the best of our knowledge, has investigated the reason for COVID-19 vaccine refusal in Cameroon in general. In order to address this question, this study investigated the determinants of COVID-19 vaccine hesitancy in the Menoua Division, West Cameroon.

2. Materials and Methods

2.1. Study Design and Period

A community-based cross-sectional and analytical study was carried out in six (06) subdivisions of the Menoua Division––namely, Dschang, Fokoué, Fongo-Tongo, Nkong-Ni, Penka-Michel, and Santchou. This study was conducted from March to April 2022.

2.2. Study Population

The study population consisted of all citizens living in the Menoua Division at the time of the study.

2.3. Inclusion and Exclusion Criteria

Men and women aged 18 and above who were willing to participate in the survey were included in the study. Vulnerable participants were excluded as well as those with incoherent data or incompletely filled questionnaires.

2.4. Sample Size and Data Collection Tool

In order to estimate a representative sample size for this study, the following formula was used:
n = Z α 2 p 1 p d ²
where n represents the sample size, p represents the prevalence, represents the 95% confidence interval, and d represents the accepted margin error of 5%, assuming a prevalence rate of 50%. The sample size of 380 participants was recorded, and it was increased by 10% of the potential reluctance rate in order to provide a minimum sample size of 460 participants. This sample was proportionally partitioned into six subdivisions regarding population size. A pre-tested questionnaire was used as a data collection tool to register the sociodemographic features of the participants as well as their knowledge about COVID-19, vaccination status, and associated factors.

2.5. Data Collection Procedure

We performed a questionnaire-based survey as described by Tendongfor et al. [15], but with some changes. Contrary to Tendongfor et al., we choose a community-based approach in order to ensure an equal chance to all of the population categories to be represented. Data collection was carried out at different markets of each subdivision. Two trained investigators were mobilized during popular market days and popular church days (Sundays) for data collection. The self-administered method was the formal strategy, but for the participants with a language or literacy barrier, investigators were allowed to fill in the response sheet after receiving the verbal consent of the participant.

2.6. Data Processing and Analysis

At the end of each collection day, the questionnaire was double-checked by the investigation team and the supervisor. Coherent and fully filled questionnaires were classified and data were tipped in Excel format using Microsoft Office Excel 2013. Data were then exported to SPSS 20.0 Software for statistical analysis. Pearson chi-square test was performed in order to determine the association between the variables. Logistic regression was used in order to test the association level of the dichotomous variables referring to the presence of COVID-19 in Cameroon, the availability of vaccine knowledge and the nearest vaccination center, and the price of vaccines. The test was considered significant if p < 0.05.
To classify the knowledge of participants, those who named the principal signs and symptoms of COVID-19, preventive measures, the nearest vaccination center, and the type of vaccines were said to have a good knowledge of COVID-19 transmission, prevention, and vaccination, respectively. Those who cited uncommon signs and symptoms and none of the vaccine types were qualified as average knowledge. Participants ignoring signs and symptoms, preventive measures, the nearest vaccination point, and the vaccines available were said to be null.

3. Results

3.1. Study Population

A representative sample of 520 participants took part in the study, which was 13.04% (n = 60) higher than the calculated sample size. Proportional to their population size, Dschang (34%, n = 177), Penka-Michel (25%, n = 130), and Nkong-Ni (20%, n = 104) were the most represented subdivisions. A total of 60.58% of the participants were female and 45.19% were single (Table 1).
The mean age of the participants was 33.27 ± 12.78, ranging from 18 to 96 years. A total of 50% (n = 260) of the participants were less than 30 years old and 11.15% (n = 58) were above 50 years old (Table 1). Participants were mostly of secondary education level (56.15%, n = 292) and trade, education, and informal sectors were the most represented professions. Health personnel accounted for 4.04% (n = 21) of the sample (Table 1).

3.2. Knowledge of the Participants on COVID-19 Manifestations

As indicated in Table 2, 65.58% of the participants had "good” and 23.65% had “average” knowledge of COVID-19 manifestations. Contrary to age, the knowledge of COVID-19 manifestations was significantly (p < 0.005) associated with gender and educational level, as female participants with a low educational level were less informed (Table 2).

3.3. Knowledge of the Participants about COVID-19 Prevention

The majority of the participants (72.31%, n = 376) had average knowledge regarding COVID-19 prevention. A total of 266 (34.54%) declared that they used medicinal plants and foods as a preventive method, and the most cited were ginger and lemon with 27.62% (n = 100) and 19.06% (n = 69), respectively (Table 3).

3.4. Profile of Plant Users as a Preventive Method against COVID-19

Considering all of the participants (n = 520), 52.68% of the female participants used one or a combination of plant products compared to 50.16% of their male counterparts. Moreover, more than 55% of the participants above 30 years old used plant products, with a record of 56.90% for those aged 50 years plus. Considering the education level, proportions of 55.06% and 57.55% of plant users were recorded in groups of participants with primary and university education level, respectively (Table 4). Plant use was significantly associated with age.

3.5. Knowledge and Attitude of the Participants to COVID-19 Vaccine

Data from Table 5 indicate that 11.92% of the participants were not aware that vaccines were present in Cameroon, while 41.61% ignored the nearest vaccination point. Regarding the role of the vaccines, almost all of the participants (92.31%) declared that they prevented COVID-19 infection, but only 27.50% of the participants qualified the vaccines as being of good quality, and 26.35% indicated death as a major side effect of the vaccine, whilst cancer (4.04%) and sterility (6.15%) were also mentioned as other vaccine side effects. A large majority of the participants (58.12%) declared that they were worried about vaccine side effects (Table 5).

3.6. Vaccinal Status of the Participants

Out of 520 participants in the study, only 52 were vaccinated, representing 10% of the total sample (Figure 1).

3.7. Profile of Vaccinated and Non-Vaccinated Participants

3.7.1. Knowledge

Table 6 summarizes the knowledge of participants regarding the presence of COVID-19 in Cameroon, the availability of vaccines, vaccination centers, and vaccine cost. A total of 90 participants denied the presence of COVID-19 in Cameroon, with 93.34% of them not vaccinated. A strong and significant (p < 0.005) association was found between vaccine acceptation and knowledge of the availability of vaccines in Cameroon, the nearest vaccination point, and the cost of the vaccines. In fact, none of the participants who ignored vaccine accessibility and the cost were vaccinated. The logistic regression confirmed that participants who were not aware of a vaccination center were more than five times less likely to take the vaccines (odds ratio: 5.18).

3.7.2. Attitude

Table 7 describes the association between the attitude of participants and vaccine acceptance. A statistically significant association (p < 0.005) was found between vaccine refusal and a participant’s belief regarding vaccine quality, side effects, and effective protection compared to medicinal plants. Almost all of the participants declared that the vaccines are of bad quality (97.97%) and that they have dangerous side effects (97.81%), and those with concerns about the side effects (96.17%) were not vaccinated. Furthermore, none of the participants using medicinal plants as a treatment option were vaccinated.

3.7.3. Personal or Sociodemographic Factors

The expression of vaccine status per age group, gender, and education level showed that vaccine acceptance was significantly associated with both age and education level. A total of 93.08% of the participants aged less than 30 years old and 93.15% of secondary education level were not vaccinated. However, gender did not affect the decision to take the vaccine (Table 8).

4. Discussion

The present study evaluated factors associated with COVID-19 vaccine refusal in the Menoua Division from March to April 2022. A community-based cross-sectional and analytical survey was conducted, and a representative sample size of 520 participants were interviewed. Since the homologation of vaccines as the principal preventive approach to COVID-19, the WHO and governments around the world have faced many challenges to equitably distribute the vaccines [4]. Despite the effectiveness of many strategies that have been put in place to facilitate the distribution of the vaccines in Africa [7], an unpredicted resistance of the population to get vaccinated has been noticed [4,13]. As documented by other studies, many theories could explain this controversy, and factual evidence has pointed to poor information or misinformation as the major factors that spark fears of potential side effects of the vaccines [6,14,16].
Participants of the present study were mostly from Dschang, Penka-Michel, and Nkong-Ni due to the high demography of these subdivisions. Males represented 60.58% of the participants, and 54.81% of the participants were married; the latter merely reflects national statistics, where about 50% of people aged between 15 and 49 years old are married [17]. The study population was young, with a mean age of 33.27 ± 12.78, and with extremes of age from 18 to 96 years old. Only 11.15% of the participants were above 50 years old. The mean age of the participants was higher than the figure of the general population in Cameroon, and it was similar to the study population described by Aseneh et al. [14]. A secondary education level was the most prevalent in the sample, and traders as well as people from the educational and informal sectors were the dominant professions. The profile of our participants was similar to that of the population studied in Kenya by Shah et al. [18]. The high proportion of participants from the informal sector could be explained by the fact that the survey was conducted at the local market, while the frequency of teachers could reflect their readiness to participate in the survey due to their intellectual level. Indeed, Dinga et al. also reported teachers as the most represented category in their survey [16]. As a consequence of the collection site, health personnel accounted for only 4.04% of the sample.
As the awareness and accessibility of a product can highly influence the decision of patients or candidates [13], we evaluated the knowledge of participants regarding COVID-19 manifestations, prevention, and vaccination. Data revealed that participants had good knowledge of COVID-19 symptoms, and that this was significantly associated with gender, age, and education level. Despite the hesitancy of the population in respecting both barrier measures and the vaccination instructions to counter the pandemic, COVID-19 remains an important matter of concern across all social categories [5]. This awareness could be the result of several sensitization campaigns held by sanitary authorities, which were a result of the government’s response strategy against COVID-19 [7]. Contrary to COVID-19 manifestations, participants showed average knowledge (72.31%) regarding prevention of the virus, and many participants preferred medicinal plants, such as ginger, lemon, garlic, and artemisia as treatment options. The limited awareness of COVID-19 prevention is consistent with the limited respect that was shown towards the preventive methods observed nationwide [5,18,19]. For some, the pandemic has already passed, and for others, COVID-19 is not dangerous and/or does not exist in Cameroon [20].
Medicinal plants have long been used in Africa for health problems. This is not only sustained by cultural habits but also due to limited and affordable health services [12,20,21]. Contrary to gender and education level, plant use was significantly associated (p < 0.005) with age, as the preference for the use of plants increased with age. The effectiveness of medicinal plants has been scientifically discussed [21,22].
The evaluation of the knowledge/attitude of participants regarding vaccines revealed poor awareness of the participants of vaccination centers and the role of vaccines. They also claimed to be very worried about the side effects of the vaccines, which included, among others, cancer, sterility, and death. These data reflect the disinterest of the population towards vaccination, and they indicate how far conspiracy theories have found a fertile ground in Africa, where people are naturally reluctant to undergo some treatments [20]. Since the beginning of the pandemic, misinformation has been shared on social media that claims COVID-19 is a planned strategy nefariously designed to control the world population, especially in Africa [20,23]. This thesis gained massive attention when the WHO predicted on 17 April 2020 that Africa would become the next epicenter of the COVID-19 pandemic [24]. A similar refractory attitude to the one we have reported towards the COVID-19 vaccines was reported in Cameroon by Ajonina-Ekoti et al. before the vaccination campaign, where about 87% of the 591 participants reported their unwillingness to receive a COVID-19 vaccine if it was available in the country [25]. Almost all of the participants ignored the role of vaccines, as 92.31% said that the vaccine prevent contamination. Unlike other vaccines, COVID-19 vaccines do not protect against infection, but, rather, prevent against severe forms of the pathology [26]. Similarly, many people believe that medicinal plants have been proven to prevent severe forms and death from COVID-19 [21,22].
Data on the knowledge and attitude of populations regarding COVID-19 prevention and vaccination were a sign of the low vaccination rate in the population. Indeed, only 10% of our study population were vaccinated. Although higher than the data found in the West African regional and national statistics, this result is far lower than the mooted 70% by June 2022 and the 60% by December 2022 that were planned by the WHO and the Cameroonian government, respectively [8,10]. These results are consistent with the reports of Patwary et al. [9] and Ajonina-Ekoti et al. [25], which indicated that at the early stage of the vaccination campaign, contrary to the 66.53% and 74.47% of people that favored vaccination in Burkina Faso and Nigeria, respectively, only 15% of Cameroonians had declared that they were likely to take the COVID-19 vaccine. These data also corroborate the reports from Drescher et al. [20], which indicated that both Cameroonians and Ivorians expressed reluctance to vaccinate right before the vaccination campaigns began. Furthermore, Murewanhema et al. [27] suggested that ignorance sustains a limited acceptance of vaccines in Zimbabwe. In this study, participants were not questioned on the number of doses of the vaccine that were taken, and this information could have permitted us to differentiate participants that were partially vaccinated from those with full protection.
In respect to the objective of the present study, the vaccine status of participants was paired to some variables, and it appeared that the lack of information, the lack of safety or the lack of confidence regarding vaccines, as well as some sociodemographic features were all significantly associated with vaccine acceptance. These features have also been documented in numerous studies in Cameroon and Africa [13,16,21].
Lack of information as a major factor affecting vaccine refusal was evidenced in this study by a significant association (p < 0.005) between vaccine status and ignorance of the presence of COVID-19 in Cameroon, as well as ignorance of the availability of vaccines, vaccination centers, and the cost of the vaccines. These associations were strengthened by logistic regression, which indicated that participants who were not aware of vaccination points were about five times more likely to not be vaccinated compared to others (add ratio: 5.18). Moreover, none of the participants who were unaware that the vaccines are available in Cameroon and are free of charge were vaccinated. Data collection for this study occurred in late April and March 2022 during the first vaccination campaign. A total of 840 vaccination centers were deployed, and a vast sensitization campaign was held with the objective of providing adequate information to at least 90% of the population [7,8]. Our results could signify that these targets were not met or that participants deliberately ignored vaccination centers in order to mark their vaccine hesitancy.
The lack of confidence towards COVID-19 vaccines was expressed by a significant association between beliefs about vaccine quality and deadly side effects, and, as a result, a preference for medicinal plants as a treatment option. In accordance with the conspiracy theory on the agenda of limiting the African population [20,25,28], 197 (37.88%) participants claimed that the vaccines were of bad quality, and 190 (36.54%) named potential severe side effects of vaccines, including gynecological cancer, sterility and death. None of the participants using the medicinal plants were vaccinated. The mistrust of vaccine quality has been reported as a leading factor towards vaccine hesitancy in many studies [29]. Our findings are also in accordance with the ideas that a high vaccine hesitancy rate is observed in people using medicinal plants or complementary medicines [12,30,31]. Considering the attitude towards COVID-19 vaccination, many researchers have focused on the curative potential of some medicinal plants against COVID-19 infection, and promising results have been revealed [32].
In our study, age and education level were also found to be significantly associated with vaccine acceptance. As older persons are more likely to be victims of COVID-19 complications, younger participants were less interested in the vaccines [33]. In contrast to those participants with primary and university education level, those with secondary education level were proportionally less vaccinated. Participants with a low level of education could be less exposed to social media and, thus, to misinformation, but this hypothesis was not verified in this study. These findings contrast with a study in France where participants with the lowest education level were more likely to refuse vaccines than other groups [34]. This study did not investigate the profession or the specific health personnel regarding their vaccination status, but many studies have reported disparities in vaccine acceptance among health personnel in Cameroon and abroad [6,35,36]. The investigation of this parameter in association with a patient’s decision to get vaccinated could help to provide in-depth information on the role of health personnel in vaccination coverage.

5. Conclusions

This study revealed that in the Menoua division, regardless of the effort of Cameroonian sanitary authorities, the vaccination rate is 10%. The lack of appropriate information, a fear of vaccine side effects, and sociodemographic features were identified as factors that have limited COVID-19 vaccine acceptance. These results indicate that the response strategy of Cameroon to disseminate COVID-19 vaccines should be reviewed, and that it should focus on sensitization in order to tackle the lack of information and/or misinformation among target groups. Local and effective solutions, including medicinal plants, could also be standardized and promoted.

Author Contributions

Conceptualization, A.C.M.T., A.A.N., P.W. and V.C.; data curation, A.L.D., A.T.T. (Armand Tsapi Tiotia), P.W. and V.C.; formal analysis, A.C.M.T., A.A.N., A.T.T. (Alaric Tamuedjoum Talom), B.T.M. and A.T.T. (Armand Tsapi Tiotia); investigation, A.C.M.T. and A.A.N.; methodology, A.A.N., A.L.D., A.T.T. (Alaric Tamuedjoum Talom) and B.T.M.; resources, A.C.M.T. and A.A.N.; software, A.T.T. (Alaric Tamuedjoum Talom) and A.T.T. (Armand Tsapi Tiotia); supervision, P.W. and V.C.; validation, V.C.; writing—original draft, A.C.M.T.; Writing—review and editing, A.A.N., A.L.D., A.T.T. (Alaric Tamuedjoum Talom), B.T.M., A.T.T. (Armand Tsapi Tiotia), P.W. and V.C. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Acknowledgments

Authors express their gratitude to the Evangelical University of Cameroon and local health administrators who provided facilities for this study.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. WHO Declares the Coronavirus Outbreak a Global Pandemic. Available online: https://www.cnbc.com/2020/03/11/who-declares-the-coronavirus-outbreak-a-global-pandemic.html (accessed on 16 September 2022).
  2. Tih, F. Cameroon Confirms First Coronavirus Case. Anadolu Agency. 2020. Available online: https://www.aa.com.tr/en/africa/cameroon-confirms-first-coronavirus-case/1756866 (accessed on 18 September 2022).
  3. Njoh, A.A.; Mboke, E.; Ndoula, S.T.; Bachir, H.B.; Nembot, R.; Chebo, C.; Aman, A.; Saidu, Y. COVID-19 in a region of Cameroon hit by armed conflict. PAMJ 2022, 41, 32. [Google Scholar] [CrossRef] [PubMed]
  4. Sallam, M.; Al-Sanafi, M.; Sallam, M. A global map of COVID-19 vaccine acceptance rates per country: An updated concise narrative review. J. Miltidiscip. Healthc. 2022, 15, 21–45. [Google Scholar] [CrossRef] [PubMed]
  5. Njoko, N.B.; Djogo, M.J.V.; Fonkoua, S.C.; Eboue, O.B.; Gaken, A.G.D.; Doloko, A.P.B.; Nkoue, P.J.J. COVID-19 Knowledge, attitudes, and practices in the community of the Evangelical University of Cameroon. Spec. J. Public Health Nutr. Diet. 2022, 2, 1–13. [Google Scholar]
  6. Voundi, E.V.; Lowe, J.M.; Abena, M.E.N.; Nseme, E.; Abbakabir, H.; Songue, E.; Kamgno, J. Anti-COVID-19 vaccination: Perception and attitudes among oral health practitioners and other health personnel in Yaoundé. Immunome Res. 2022, 18, 5. [Google Scholar]
  7. Amani, A.; Njoh, A.A.; Fouda, A.A.B.; Ndoula, S.; Abba-Kabir, H.M.; Mossus, T.; Nguefack-Tsague, G.; Kamgno, J. The first 30 days of COVID-19 vaccination in Cameroon: Achievements, challenges, and lessons learned. PAMJ 2022, 41, 201. [Google Scholar] [PubMed]
  8. Amani, A.; Njoh, A.A.; Mouangue, C.; Cheuyem, L.F.Z.; Mossus, T. Vaccination coverage and safety in Cameroon: Descriptive assessment of COVID-19 infection in vaccinated individuals. Health Sci. Dis. 2022, 23, 1–8. [Google Scholar]
  9. Patwary, M.M.; Alam, M.A.; Bardhan, M.; Disha, A.S.; Haque, M.Z.; Billah, S.M.; Kabir, M.P.; Browning, M.H.; Rahman, M.M.; Parsa, A.D.; et al. COVID-19 Vaccine Acceptance among Low- and Lower-Middle-Income Countries: A Rapid Systematic Review and Meta-Analysis. Vaccines 2022, 10, 427. [Google Scholar] [CrossRef] [PubMed]
  10. Centre Régional de Prévention et de Lutte Contre les Epidémies de l’Ouest-Cameroun. Rapport Situationnel des Actions de Riposte Contre la COVID-19 et le Choléra; Centre Régional de Prévention et de Lutte Contre les Epidémies de l’Ouest-Cameroun: Yaoundé, Cameroon, 2022. [Google Scholar]
  11. MacDonald, N.E. Vaccine hesitancy: Definition, scope and determinants. Vaccines 2015, 33, 4161–4164. [Google Scholar] [CrossRef]
  12. Hassen, H.D.; Welde, M.; Menebo, M.M. Understanding determinants of COVID-19 vaccine hesitancy; an emphasis on the role of religious affiliation and individual’s reliance on traditional remedy. BMC Public Health 2022, 22, 1142. [Google Scholar] [CrossRef]
  13. Kabakama, S.; Konje, E.T.; Dinga, J.N.; Kishamawe, C.; Morhason-Bello, I.; Hayombe, P.; Adeyemi, O.; Chimuka, E.; Lumu, I.; Amuasi, J.; et al. Commentary on COVID-19 Vaccine Hesitancy in sub-Saharan Africa. Trop. Med. Infect. Dis. 2022, 7, 130. [Google Scholar] [CrossRef]
  14. Aseneh, J.B.; Agbor, V.N.; Kadia, B.; Okolie, E.A.; Ofomata, C.J.; Etombi, C.L.; Ekaney, D.S.M.; Fru, Y.W.J. Factors associated with COVID-19 vaccine hesitancy among healthcare workers in Cameroon and Nigeria: A web-based cross-sectional study. Int. Health 2022. online ahead of print. [Google Scholar] [CrossRef] [PubMed]
  15. Nicholas, T.; Vanessa, A.B.T.; Destin, K.T.G. Psychological Impact of Covid-19 among Healthcare Workers in Cameroon. J. Healthc. 2021, 4, 47–55. [Google Scholar] [CrossRef]
  16. Dinga, J.N.; Sinda, L.K.; Titanji, V.P.K. Assessment of vaccine hesitancy to a COVID-19 vaccine in Cameroonian adults and its global implication. Vaccines 2021, 9, 175. [Google Scholar] [CrossRef]
  17. Institut National de la Statistique (INS). Enquête Démographique et de Santé; Institut National de la Statistique (INS): Yaoundé, Cameroon, 2018; 737p. [Google Scholar]
  18. Shah, J.; Abeid, A.; Sharma, K.; Manji, S.; Nambafu, J.; Korom, R.; Patel, K.; Said, M.; Mohamed, M.A.; Sood, M.; et al. Perceptions and Knowledge towards COVID-19 Vaccine Hesitancy among a Subpopulation of Adults in Kenya: An English Survey at Six Healthcare Facilities. Vaccines 2022, 10, 705. [Google Scholar] [CrossRef] [PubMed]
  19. Ngah, Y.E.; Cho, F.N.; Etagha, B.S.; Ibrahim, N.; Elad, P.C.K.; Jokwi, P.K.; Ikomey, M.G. Knowledge, Attitudes, and Practices of/towards Covid-19 among Cameroonians in the Bamenda Health District: A Cross-Sectional Study during the Second Wave of the Pandemic. Texila Int. J. Public Health 2022, 10, e0008700. [Google Scholar] [CrossRef]
  20. Drescher, M.; Boukari, O.; Liliane, C.; Mbaho, N. Beaucoup de Peur et de Questionnement: Une Etude Comparative des Discours sur le COVID-19 en Côte d’Ivoire et au Cameroun; University of Bayreuth, African Studies: Bayreuth, Germany, 2022; 37p. [Google Scholar] [CrossRef]
  21. Popoola, T.D.; Segun, P.A.; Ekuadzi, E.; Dickson, R.A.; Awotona, O.R.; Nahar, L.; Sarker, S.D.; Fatokun, A.A. West African medicinal plants and their constituent compounds as treatments for viral infections, including SARS-CoV-2/COVID-19. DARU J. Pharm. Sci. 2022, 30, 191–210. [Google Scholar] [CrossRef] [PubMed]
  22. Alaba, F.B.J.; Avestruz, P.R.S.D.; Cordero, R.R.A.; Erum, E.L.; Sumampong, M.M.Q.; Abiso-Padilla, J. Essential Oils of Allium Sativum and Eucalyptus Globulus as Antagonists for Sars-Cov-2 Infection: A Review. Int. J. Res. Public Rev. 2022, 1, 404–416. [Google Scholar]
  23. Apetrei, C.; Marx, P.A.; Mellors, J.W.; Pandrea, I. The COVID misinfodemic: Not new, never more lethal. Trends Microbiol. 2022, 30, 948–958. [Google Scholar] [CrossRef]
  24. Fokoua-Maxime, C.D.; Bellouche, Y.; Tchigui-Ariolle, D.N.; Tchato-Yann, T.L.; Choukem, S.P. The spread and burden of the COVID-19 pandemic in sub-Saharan Africa: Comparison between predictions and actual data and lessons learned. BM J. Yale 2022, in press. [CrossRef]
  25. Ajonina-Ekoti, I.U.; Ware, K.B.; Nfor, C.K.; Akomoneh, E.A.; Djam, A.; Chia-Garba, M.; Wepnyu, G.N.; Awambeng, D.; Abendong, K.; Manjong, F.T.; et al. COVID-19 perceptions and vaccine hesitancy: Acceptance, attitude, and barriers among Cameroonians. J. Am. Pharm. Assoc. 2022, 62, 1823–1829. [Google Scholar] [CrossRef]
  26. Noruzi, A.; Gholampour, B.; Gholampour, S.; Jafari, S.; Farshid, R.; Stanek, A.; Saboury, A.A. Current and Future Perspectives on the COVID-19 Vaccine: A Scientometric Review. J. Clin. Med. 2022, 11, 750. [Google Scholar] [CrossRef]
  27. Murewanhema, G.; Musuk, G.; Mukwenha, S.; Chingombe, I.; Dzinamarira, T. Hesitancy, ignorance or uncertainty? The need for effective communication strategies as Zimbabwe’s uptake of COVID-19 vaccine booster doses remains poor. Public Health Pract. 2022, 3, 100244. [Google Scholar] [CrossRef] [PubMed]
  28. Pertwee, E.; Simas, C.; Larson, H.J. An epidemic of uncertainty: Rumors, conspiracy theories and vaccine hesitancy. Nat. Med. 2022, 28, 456–459. [Google Scholar] [CrossRef] [PubMed]
  29. Pires, C. Global Predictors of COVID-19 Vaccine Hesitancy: A Systematic Review. Vaccines 2022, 10, 1349. [Google Scholar] [CrossRef] [PubMed]
  30. Wong, L.; Wong, P.; AbuBakar, S. Vaccine hesitancy and the resurgence of vaccine preventable diseases: The way forward for Malaysia, a Southeast Asian country. Hum. Vaccines Immunother. 2020, 16, 1511–1520. [Google Scholar] [CrossRef] [PubMed]
  31. Sreekumar, S.; Nisha, N.C. Plants are Renewable Source of Medicine and Nanoparticles: A Review. Curr. Asp. Pharm. Res. Dev. 2022, 8, 44–56. [Google Scholar]
  32. Mukherjee, P.K.; Efferth, T.; Das, B.; Kar, A.; Ghosh, S.; Singha, S.; Debnath, P.; Sharma, N.; Bhardwaj, P.K.; Haldar, P.K. Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications. Phytomedicine 2022, 98, 153930. [Google Scholar] [CrossRef] [PubMed]
  33. Gorelik, Y.; Anis, E.; Edelstein, M. Inequalities in initiation of COVID19 vaccination by age and population group in Israel- December 2020–July 2021. Lancet Reg. Health Eur. 2022, 12, 100234. [Google Scholar] [CrossRef]
  34. Bajos, N.; Spire, A.; Silberzan, L.; EPICOV study group. The social specificities of hostility toward vaccination against COVID-19 in France. PLoS ONE 2022, 17, e0262192. [Google Scholar] [CrossRef]
  35. Heyerdahl, L.W.; Dielen, S.; Nguyen, T.; Van Riet, C.; Kattumana, T.; Simas, C.; Vandaele, N.; Vandamme, A.M.; Vandermeulen, C.; Giles-Vernick, T.; et al. Doubt at the core: Unspoken vaccine hesitancy among healthcare workers. Lancet Reg. Health Eur. 2022, 12, 100289. [Google Scholar] [CrossRef]
  36. Peterson, C.J.; Lee, B.; Nugent, K. COVID-19 Vaccination Hesitancy among Healthcare Workers-A Review. Vaccines 2022, 10, 948. [Google Scholar] [CrossRef]
Figure 1. Vaccination status of participants.
Figure 1. Vaccination status of participants.
Tropicalmed 08 00424 g001
Table 1. Sociodemographic characteristics of the study population.
Table 1. Sociodemographic characteristics of the study population.
Sociodemographic CharacteristicsNumberFrequency
Participants per subdivision
Dschang17734.04
Fokoué173.27
Fongo-Tongo326.15
Nkong-Ni10620.38
Penka-Michel12824.62
Santchou6011.54
Gender
Male31560.58
Female20539.42
Marital status
Single23545.19
Married28554.81
Age groups
<3026050.00
[30–50]20238.85
>505811.15
Education level
Primary8917.12
Secondary29256.15
University13926.73
Professions
Civil servants61.15
Informal sector17734.04
Health sector214.04
Traders17734.04
Education sector13926.73
Table 2. Knowledge of the participants of COVID-19 manifestations, and its association with gender, education, and age.
Table 2. Knowledge of the participants of COVID-19 manifestations, and its association with gender, education, and age.
VariablesKnowledge Level (n (%))Totalp Value
GoodAverageNull
Gender
Female152 (74.15)35 (17.07)18 (8.78)2050.003
Male189 (60.00)88 (27.94)38 (12.06)315
Total341 [65.58]123 [23.65]56 [10.77]520
Education Level
Primary44 (49.44)30 (33.70)15 (16.85)890.000
Secondary184 (63.01)73 (25.00)35 (11.99)292
University113 (81.29)20 (14.39)6 (4.32)139
Total341 [65.58]123 [23.65]56 [10.77]520
Age Groups
<30174 (66.92)60 (23.08)26 (10.00)2600.178
[30–50]131 (64.85)50 (24.75)21 (10.40)202
>5036 (62.07)13 (22.41)9 (15.52)58
Total341 [65.58]123 [23.65]56 [10.77]520
(): percentage in raw; []: percentage in the column.
Table 3. Knowledge of the participants on COVID-19 prevention and preventive methods.
Table 3. Knowledge of the participants on COVID-19 prevention and preventive methods.
VariablesNumberFrequency (%)
Knowledge of COVID-19 prevention
Good10820.77
Average37672.31
Null366.92
Total520100
Preventive methods
Barriers measures47661.81
Medicinal plants26634.54
Total770100
Most cited plants
Common namesScientific names
GingerZingiber officinale10027.62
LemonCitrus limon6919.06
GarlicAllium sativum6417.67
ArtemisiaArtemisia sp. 6217.12
LemongrassCymbopogon citratus277.47
Aloe veraAloe vera267.19
KinkelibaCombretum micranthum143.87
Table 4. Profile of medicinal plants users as a preventive method against COVID-19.
Table 4. Profile of medicinal plants users as a preventive method against COVID-19.
VariablesGenderAge GroupsEducation
ModalityFemaleMale<30[30–50]>50PrimarySecondaryUniversity
Number108158120113334913780
%52.6850.1646.1555.9456.9055.0646.9257.55
p-value0.640.0040.08
%: Percentage of the total modality in the sample.
Table 5. Knowledge and attitude of the participants towards the COVID-19 vaccine.
Table 5. Knowledge and attitude of the participants towards the COVID-19 vaccine.
VariablesModalitiesNumberFrequency (%)
Availability of the vaccine in CameroonDon’t know 224.23
Not available 6211.92
Available 43683.85
Nearest vaccination centerDon’t know21641.54
Know 30458.56
Role of vaccinesPrevent hospitalization 407.69
Prevent contamination37992.31
Quality of vaccinesDon’t know18034.61
Good quality14327.5
Bad quality19745.18
Side effectsGynaecologic cancers214.04
Sterility326.15
Death13726.35
Other33063.46
Worried about side effectsNo21841.92
A bit6712.88
Very23545.19
Table 6. Association between knowledge and COVID-19 vaccine status in the Menoua Division.
Table 6. Association between knowledge and COVID-19 vaccine status in the Menoua Division.
VariablesVaccinal Statusp-ValueOdd Ratio
VaccinatedNon Vaccinated
Number FrequencyNumberFrequency
Presence of COVID-19 in Cameroon
No66.668493.340.851.67
Yes4610.7038489.30
Total5210.0046890.00
Availability of vaccines in Cameroon
No00.0084100.000.0011.135
Yes 5211.9238488.08
Total5210.0046890.00
Knowledge on the nearest vaccination center
Don’t know73.2420996.760.0005.18
Know4514.8025985.20
Total5252.0046890.00
Are vaccines free
Yes 5217.8545182.150.00017.58
No 00.0017100.00
Total5210.0046890.00
Table 7. Association between the population’s attitude and COVID-19 vaccine status in the Menoua Division.
Table 7. Association between the population’s attitude and COVID-19 vaccine status in the Menoua Division.
VariablesVaccination Statusp-Value
VaccinatedNon-Vaccinated
Number%Number%
Vaccine quality
Good4382.6910021.370.000
Bad47.6919341.24
Don’t know59.6217537.39
Total52100.00468100.00
Side effects
Gynaecologic cancer23.85194.060.002
Sterility35.77296.20
Death35.7713428.63
Others4484.6228661.11
Total52100.00468100.00
Worried about side effects
No3873.0818038.460.000
A bit59.626213.25
Very917.3122648.29
Total52100.00468100.00
Plants provide better prevention
Yes 00.0088100.000.000
No5210.0038090.00
Total5210.0046890.00
Table 8. Sociodemographic factors associated with COVID-19 vaccine status in the Menoua Division.
Table 8. Sociodemographic factors associated with COVID-19 vaccine status in the Menoua Division.
Variables Vaccination Statusp-Value
VaccinatedNon-Vaccinated
NumberFrequencyNumberFrequency
Age groups
<301834.6224251.710.00
[30–50]2446.1517838.03
>501019.234810.26
Total52100.00468100.00
Gender
Female2446.1518138.680.184
Male2853.8528761.32
Total52100.00468100.00
Education level
Primary1121.157816.670.019
Secondary2038.4627258.12
University2140.3811825.21
Total52100.00468100.00
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Tetsatsi, A.C.M.; Nguena, A.A.; Deutou, A.L.; Talom, A.T.; Metchum, B.T.; Tiotsia, A.T.; Watcho, P.; Colizzi, V. Factors Associated with COVID-19 Vaccine Refusal: A Community-Based Study in the Menoua Division in Cameroon. Trop. Med. Infect. Dis. 2023, 8, 424. https://doi.org/10.3390/tropicalmed8090424

AMA Style

Tetsatsi ACM, Nguena AA, Deutou AL, Talom AT, Metchum BT, Tiotsia AT, Watcho P, Colizzi V. Factors Associated with COVID-19 Vaccine Refusal: A Community-Based Study in the Menoua Division in Cameroon. Tropical Medicine and Infectious Disease. 2023; 8(9):424. https://doi.org/10.3390/tropicalmed8090424

Chicago/Turabian Style

Tetsatsi, Aimé Césaire Momo, Astride Arolle Nguena, Andrillene Laure Deutou, Alaric Tamuedjoun Talom, Beatrice Talom Metchum, Armand Tsapi Tiotsia, Pierre Watcho, and Vittorio Colizzi. 2023. "Factors Associated with COVID-19 Vaccine Refusal: A Community-Based Study in the Menoua Division in Cameroon" Tropical Medicine and Infectious Disease 8, no. 9: 424. https://doi.org/10.3390/tropicalmed8090424

Article Metrics

Back to TopTop